表紙:多重アッセイ市場:世界の業界分析、規模、シェア、成長、動向、予測(2018~2026年)
市場調査レポート
商品コード
763050

多重アッセイ市場:世界の業界分析、規模、シェア、成長、動向、予測(2018~2026年)

Multiplex Assays Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

出版日: | 発行: Transparency Market Research | ページ情報: 英文 333 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=114.10円
多重アッセイ市場:世界の業界分析、規模、シェア、成長、動向、予測(2018~2026年)
出版日: 2018年11月13日
発行: Transparency Market Research
ページ情報: 英文 333 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の多重アッセイ市場について調査し、市場の動向とセグメント別動向、地域別予測、市場に参入する企業のプロファイルについてまとめています。

第1章 序論

第2章 仮定と略語

第3章 調査方法

第4章 エグゼクティブサマリー

第5章 市場概要

  • 製品概要
  • 市場動向
    • 促進因子
    • 阻害因子
    • 機会
    • 動向
  • 市場価値予測
  • 市場見通し
  • 主な業界動向
  • ポーターズファイブフォース分析
  • 比較分析
  • 関連する手続き
  • バリューチェーン分析
  • 流通業者リスト
  • 主な規制機関
  • 法規制認可プロセス

第6章 製品別市場分析

  • イントロダクション
  • 主な調査結果
  • 市場価値シェア分析
  • 市場価値予測
    • 計器
    • 消耗品
    • ソフトウェア
  • 市場の魅力度

第7章 技術別市場分析

  • イントロダクション
  • 主な調査結果
  • 市場価値シェア分析
  • 市場価値予測
    • 多重RT-PCR
    • フローサイトメトリ
    • 発光
    • 蛍光分析
    • その他
  • 市場の魅力度

第8章 タイプ別市場分析

  • イントロダクション
  • 主な調査結果
  • 市場価値シェア分析
  • 市場価値予測
    • タンパク質
    • 核酸
    • 細胞
  • 市場の魅力度

第9章 用途別市場分析

  • イントロダクション
  • 主な調査結果
  • 市場価値シェア分析
  • 市場価値予測
    • 研究開発
    • 診断
    • その他
  • 市場の魅力度

第10章 エンドユーザー別市場分析

  • イントロダクション
  • 主な調査結果
  • 市場価値シェア分析
  • 市場価値予測
    • 学術研究センター
    • バイオテクノロジー・バイオ医薬品メーカー
    • 診断センター
    • 病院
    • その他
  • 市場の魅力度

第11章 地域別市場分析と予測

  • イントロダクション
  • 地域別見通し
  • 市場価値予測
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • 市場の魅力度

第12章 米国市場

第13章 欧州市場

第14章 アジア太平洋地域市場

第15章 ラテンアメリカ市場

第16章 中東・アフリカ市場

第17章 競合環境

  • 競合マトリクス
  • 企業プロファイル
図表

List of Tables

  • Table 01: Multiplex Assays- List of Distributors
  • Table 02: Key Regulatory Agencies
  • Table 03: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 04: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016-2026
  • Table 05: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 06: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 07: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016-2026
  • Table 08: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016-2026
  • Table 09: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 10: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016-2026
  • Table 11: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016-2026
  • Table 12: Global Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 13: Global Multiplex Assays Market Value (US$ Mn) Forecast, by Region, 2016-2026
  • Table 14: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Country, 2016-2026
  • Table 15: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 16: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016-2026
  • Table 17: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 18: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 19: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016-2026
  • Table 20: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016-2026
  • Table 21: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 22: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016-2026
  • Table 23: North America Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016-2026
  • Table 24: North America Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 25: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 26: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 27: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Product- Consumables, 2016-2026
  • Table 28: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 29: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 30: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016-2026
  • Table 31: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016-2026
  • Table 32: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 33: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016-2026
  • Table 34: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016-2026
  • Table 35: Europe Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 36: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 37: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 38: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016-2026
  • Table 39: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 40: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 41: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016-2026
  • Table 42: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016-2026
  • Table 43: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 44: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016-2026
  • Table 45: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016-2026
  • Table 46: Asia Pacific Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 47: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016-2026
  • Table 48: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 49: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016-2026
  • Table 50: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 51: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 52: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016-2026
  • Table 53: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016-2026
  • Table 54: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 55: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016-2026
  • Table 56: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016-2026
  • Table 57: Latin America Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016-2026
  • Table 58: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Country/Sub-regions, 2016-2026
  • Table 59: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Product, 2016-2026
  • Table 60: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Consumables, 2016-2026
  • Table 61: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Technology, 2016-2026
  • Table 62: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Type, 2016-2026
  • Table 63: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Protein, 2016-2026
  • Table 64: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Nucleic Acid, 2016-2026
  • Table 65: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Application, 2016-2026
  • Table 66: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Research & Development, 2016-2026
  • Table 67: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by Diagnosis, 2016-2026
  • Table 68: Middle East & Africa Multiplex Assays Market Value (US$ Mn) Forecast, by End-user, 2016-2026

List of Figures

  • Figure 01: Multiplex Assays Market Value (US$ Mn) and Distribution by Geography, 2017 and 2026
  • Figure 02: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%), and Forecast, 2018-2026
  • Figure 03: Global Multiplex Assays Market Value Share, by Product (2018)
  • Figure 04: Global Multiplex Assays Market Value Share, by Technology (2018)
  • Figure 05: Global Multiplex Assays Market Value Share, by Type (2018)
  • Figure 06: Global Multiplex Assays Market Value Share, by Application (2018)
  • Figure 07: Global Multiplex Assays Market Value Share, by End-user (2018)
  • Figure 08: Global Multiplex Assays Market Value Share, by Region (2018)
  • Figure 09: Porter's Five Force Analysis
  • Figure 10: Steps Involved in Performing Multiplex Assay
  • Figure 11: Value Chain Analysis
  • Figure 12: U.S. Regulatory Approval Process
  • Figure 13: Europe Regulatory Approval Process
  • Figure 14: Japan Regulatory Approval Process
  • Figure 15: India Regulatory Approval Process
  • Figure 16: Latin America Regulatory Approval Process
  • Figure 17: Global Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 18: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Instruments, 2016-2026
  • Figure 19: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Consumables, 2016-2026
  • Figure 20: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Software, 2016-2026
  • Figure 21: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Reagents & Kits, 2016-2026
  • Figure 22: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Micropipettes and Microplates, 2016-2026
  • Figure 23: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 24: Global Multiplex Assays Market Attractiveness, by Product, 2018?2026
  • Figure 25: Global Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
  • Figure 26: Global Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
  • Figure 27: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Multiplex RT-PCR, 2016-2026
  • Figure 28: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Flow Cytometry, 2016-2026
  • Figure 29: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Luminescence, 2016-2026
  • Figure 30: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Fluorescence, 2016-2026
  • Figure 31: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 32: Global Multiplex Assays Market Attractiveness, by Technology, 2018?2026
  • Figure 33: Global Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 34: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Protein, 2016-2026
  • Figure 35: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Nucleic Acid, 2016-2026
  • Figure 36: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cell, 2016-2026
  • Figure 37: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Planar, 2016-2026
  • Figure 38: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bead-based, 2016-2026
  • Figure 39: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Planar, 2016-2026
  • Figure 40: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Bead-based, 2016-2026
  • Figure 41: Global Multiplex Assays Market Attractiveness, by Type, 2018?2026
  • Figure 42: Global Multiplex Assays Market Attractiveness, by Protein, 2018?2026
  • Figure 43: Global Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
  • Figure 44: Global Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 45: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Research & Development, 2016-2026
  • Figure 46: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnosis, 2016-2026
  • Figure 47: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 48: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Drug Discovery & Development, 2016-2026
  • Figure 49: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biomarker research & Application, 2016-2026
  • Figure 50: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Infectious Diseases, 2016-2026
  • Figure 51: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Autoimmune Diseases, 2016-2026
  • Figure 52: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cancer, 2016-2026
  • Figure 53: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiovascular Diseases, 2016-2026
  • Figure 54: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Neuro-endocrine Diseases, 2016-2026
  • Figure 55: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 56: Global Multiplex Assays Market Attractiveness, by Application, 2018?2026
  • Figure 57: Global Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
  • Figure 58: Global Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
  • Figure 59: Global Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 60: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Academic and Research Centers, 2016-2026
  • Figure 61: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Centers, 2016-2026
  • Figure 62: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biotechnology and Biopharmaceutical Companies, 2016-2026
  • Figure 63: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2016-2026
  • Figure 64: Global Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2016-2026
  • Figure 65: Global Multiplex Assays Market Attractiveness, by End-user, 2018?2026
  • Figure 66: Global Multiplex Assays Market Value (US$ Mn) Forecast, 2016-2026
  • Figure 67: Global Multiplex Assays Market Value Share Analysis, by Region, 2017 and 2026
  • Figure 68: Global Multiplex Assays Market Attractiveness, by Region, 2018-2026
  • Figure 69: North America Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016-2026
  • Figure 70: North America Multiplex Assays Market Attractiveness Analysis, by Country, 2018-2026
  • Figure 71: North America Multiplex Assays Market Value Share Analysis, by Country, 2017 and 2026
  • Figure 72: North America Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 73: North America Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
  • Figure 74: North America Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 75: North America Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 76: North America Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 77: North America Multiplex Assays Market Attractiveness, by Product, 2018?2026
  • Figure 78: North America Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
  • Figure 79: North America Multiplex Assays Market Attractiveness, by Type, 2018?2026
  • Figure 80: North America Multiplex Assays Market Attractiveness, by Protein, 2018?2026
  • Figure 81: North America Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
  • Figure 82: North America Multiplex Assays Market Attractiveness, by Application, 2018?2026
  • Figure 83: North America Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
  • Figure 84: North America Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
  • Figure 85: North America Multiplex Assays Market Attractiveness, by Technology, 2018?2026
  • Figure 86: North America Multiplex Assays Market Attractiveness, by End-user, 2018?2026
  • Figure 87: Europe Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016-2026
  • Figure 88: Europe Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 89: Europe Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 90: Europe Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 91: Europe Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
  • Figure 92: Europe Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 93: Europe Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 94: Europe Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 95: Europe Multiplex Assays Market Attractiveness, by Product, 2018?2026
  • Figure 96: Europe Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
  • Figure 97: Europe Multiplex Assays Market Attractiveness, by Type, 2018?2026
  • Figure 98: Europe Multiplex Assays Market Attractiveness, by Protein, 2018?2026
  • Figure 99: Europe Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
  • Figure 100: Europe Multiplex Assays Market Attractiveness, by Application, 2018?2026
  • Figure 101: Europe Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
  • Figure 102: Europe Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
  • Figure 103: Europe Multiplex Assays Market Attractiveness, by Technology, 2018?2026
  • Figure 104: Europe Multiplex Assays Market Attractiveness, by End-user, 2018?2026
  • Figure 105: Asia Pacific Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016-2026
  • Figure 106: Asia Pacific Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 107: Asia Pacific Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 108: Asia Pacific Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 109: Asia Pacific Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
  • Figure 110: Asia Pacific Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 111: Asia Pacific Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 112: Asia Pacific Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 113: Asia Pacific Multiplex Assays Market Attractiveness, by Product, 2018?2026
  • Figure 114: Asia Pacific Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
  • Figure 115: Asia Pacific Multiplex Assays Market Attractiveness, by Type, 2018?2026
  • Figure 116: Asia Pacific Multiplex Assays Market Attractiveness, by Protein, 2018?2026
  • Figure 117: Asia Pacific Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
  • Figure 118: Asia Pacific Multiplex Assays Market Attractiveness, by Application, 2018?2026
  • Figure 119: Asia Pacific Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
  • Figure 120: Asia Pacific Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
  • Figure 121: Asia Pacific Multiplex Assays Market Attractiveness, by Technology, 2018?2026
  • Figure 122: Asia Pacific Multiplex Assays Market Attractiveness, by End-user, 2018?2026
  • Figure 123: Latin America Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016-2026
  • Figure 124: Latin America Multiplex Assays Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
  • Figure 125: Latin America Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 126: Latin America Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 127: Latin America Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
  • Figure 128: Latin America Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 129: Latin America Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 130: Latin America Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 131: Latin America Multiplex Assays Market Attractiveness, by Product, 2018?2026
  • Figure 132: Latin America Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
  • Figure 133: Latin America Multiplex Assays Market Attractiveness, by Type, 2018?2026
  • Figure 134: Latin America Multiplex Assays Market Attractiveness, by Protein, 2018?2026
  • Figure 135: Latin America Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
  • Figure 136: Latin America Multiplex Assays Market Attractiveness, by Application, 2018?2026
  • Figure 137: Latin America Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
  • Figure 138: Latin America Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
  • Figure 139: Latin America Multiplex Assays Market Attractiveness, by Technology, 2018?2026
  • Figure 140: Latin America Multiplex Assays Market Attractiveness, by End-user, 2018?2026
  • Figure 141: Middle East & Africa Multiplex Assays Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016-2026
  • Figure 142: Middle East & Africa Multiplex Assays Market Attractiveness Analysis, by Country/Sub-regions, 2018-2026
  • Figure 143: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
  • Figure 144: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Product, 2017 and 2026
  • Figure 145: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Technology, 2017 and 2026
  • Figure 146: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Type, 2017 and 2026
  • Figure 147: Middle East & Africa Multiplex Assays Market Value Share Analysis, by Application, 2017 and 2026
  • Figure 148: Middle East & Africa Multiplex Assays Market Value Share Analysis, by End-user, 2017 and 2026
  • Figure 149: Middle East & Africa Multiplex Assays Market Attractiveness, by Product, 2018?2026
  • Figure 150: Middle East & Africa Multiplex Assays Market Attractiveness, by Consumables, 2018?2026
  • Figure 151: Middle East & Africa Multiplex Assays Market Attractiveness, by Type, 2018?2026
  • Figure 152: Middle East & Africa Multiplex Assays Market Attractiveness, by Protein, 2018?2026
  • Figure 153: Middle East & Africa Multiplex Assays Market Attractiveness, by Nucleic Acid, 2018?2026
  • Figure 154: Middle East & Africa Multiplex Assays Market Attractiveness, by Application, 2018?2026
  • Figure 155: Middle East & Africa Multiplex Assays Market Attractiveness, by Research & Development, 2018?2026
  • Figure 156: Middle East & Africa Multiplex Assays Market Attractiveness, by Diagnosis, 2018?2026
  • Figure 157: Middle East & Africa Multiplex Assays Market Attractiveness, by Technology, 2018?2026
  • Figure 158: Middle East & Africa Multiplex Assays Market Attractiveness, by End-user, 2018?2026
目次

Title:
Multiplex Assays Market (Product- Instruments, Consumables (Reagents and Kits, Micropipettes and Microplates), Software; Technology - Multiplex RT-PCR, Flow Cytometry, Fluorescence, Luminescence; Type - Protein (Planar, Bead based), Nucleic Acid (Planar, Bead based), Cell; Application - Research and Development (Drug Discovery and Development, Biomarker Research and Application), Diagnosis (Infectious Diseases, Autoimmune Diseases, Cancer, Cardiovascular Diseases, Neuro-endocrine Diseases); End use - Academic and Research Centers, Diagnostic Centers, Biotechnology and Biopharmaceutical Companies, Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026.

Global Multiplex Assays Market: Overview

The global multiplex assays market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on product, technology, type, application, end-user, and region. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the overview section. Additionally, the section comprises competitive matrix and company profiles along with business overview to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis by geography and market share analysis by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global multiplex assays market.

Global Multiplex Assays Market: Key Segments

In terms of product, the global multiplex assays market has been segmented into instruments, consumables, and software. The consumables segment has been further categorized into reagents & kits, micropipettes and microplates, and others. Expansion of the consumables segment is primarily due to repeat orders for reagents and kits. Additionally, the market has been segmented based on technology, type, and application.

Based on end-user, the global multiplex assays market has been classified into biotechnology & biopharmaceutical companies, academic & research centers, diagnostic centers, hospitals, and others. The biotechnology & biopharmaceutical companies segment is anticipated to expand at a significant CAGR during the forecast period. The market has been analyzed based on price variations, technology trend, and presence of key players. The market size and forecast for each of these segments have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year.

Global Multiplex Assays Market: Regional Outlook

In terms of region, the global multiplex assays market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles the major players in the market in terms of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Key companies profiled in the global multiplex assays market include Luminex Corporation, Thermo Fisher Scientific, Inc., Seegene, Inc., Meso Scale Diagnostics, LLC., Abcam plc, Bio-Rad Laboratories, Inc., QIAGEN N.V., Merck KGaA, Quansys Biosciences, and Illumina, Inc.

The global multiplex assays market has been segmented as follows:

Global Multiplex Assays Market, by Product

  • Instruments
  • Consumables
  • Reagents & Kits
  • Micropipettes & Microplates
  • Others
  • Software

Global Multiplex Assays Market, by Technology

  • Multiplex RT-PCR
  • Flow Cytometry
  • Luminescence
  • Fluorescence
  • Others

Global Multiplex Assays Market, by Type

  • Protein
  • Planar
  • Bead-based
  • Nucleic Acid
  • Planar
  • Bead-based
  • Cell

Global Multiplex Assays Market, by Application

  • Research & Development
  • Drug Discovery & Research
  • Biomarker Research & Application
  • Diagnosis
  • Infectious Diseases
  • Autoimmune Diseases
  • Cancer
  • Cardiovascular Diseases
  • Neuro-endocrine Diseases
  • Others
  • Others

Global Multiplex Assays Market, by End-user

  • Biotechnology & Biopharmaceutical Companies
  • Academic & Research Centers
  • Diagnostic Centers
  • Hospitals
  • Others

Global Multiplex Assays Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Australia
    • India
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • GCC Countries
    • Israel
    • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Report Scope and Market Segmentation
  • 1.2. Research Highlights

2. Assumptions and Acronyms Used

3. Research Methodology

4. Executive Summary

5. Market Overview

  • 5.1. Product Overview
  • 5.2. Market Dynamics
    • 5.2.1. Drivers
      • 5.2.1.1. Advantages of multiplex assays over singleplex assays
      • 5.2.1.2. Government and non-government funding
      • 5.2.1.3. Rise in prevalence of infectious diseases and cancer
      • 5.2.1.4. Strategic acquisitions and partnerships
      • 5.2.1.5. Increasing applications of multiplex assays
      • 5.2.1.6. Significant product launches
    • 5.2.2. Restraints
      • 5.2.2.1. Lack of skilled labor
      • 5.2.2.2. High cost of multiplex assay systems
      • 5.2.2.3. Constraints of multiplex assays
      • 5.2.2.4. Stringent regulatory environment
      • 5.2.2.5. Product recalls
    • 5.2.3. Opportunities
      • 5.2.3.1. Rise in focus on multiplexed point-of-care testing
      • 5.2.3.2. Combining multiplex assays with microchip arrays
    • 5.2.4. Trends
      • 5.2.4.1. Increase in the number of biotechnology companies
      • 5.2.4.2. Growing need for personalized medicine
  • 5.3. Global Multiplex Assays Market Value (US$ Mn) Forecast, 2016?2026
  • 5.4. Global Multiplex Assays Market Outlook
  • 5.5. Key Industry Developments
  • 5.6. Porter's Five Forces Analysis
  • 5.7. Comparative Analysis - Multiplex Assays vs Singleplex Assays
  • 5.8. Comparative Analysis - Planar and Bead-based Multiplex Assays
  • 5.9. Multiplex Assay - Steps Involved
  • 5.10. Value Chain Analysis
  • 5.11. Multiplex Assays - List of Distributors
  • 5.12. Key Regulatory Agencies
  • 5.13. Regulatory Approval Process
    • 5.13.1. U.S.
    • 5.13.2. Europe
    • 5.13.3. Asia Pacific
    • 5.13.4. Latin America
    • 5.13.5. Middle East & Africa

6. Global Multiplex Assays Market Analysis, by Product

  • 6.1. Introduction
  • 6.2. Key Findings
  • 6.3. Global Multiplex Assays Market Value Share Analysis, by Product
  • 6.4. Global Multiplex Assays Market Value Forecast, by Product, 2016?2026
    • 6.4.1. Instruments
    • 6.4.2. Consumables
      • 6.4.2.1. Reagents & Kits
      • 6.4.2.2. Micropipettes & Microplates
      • 6.4.2.3. Others
    • 6.4.3. Software
  • 6.5. Global Multiplex Assays Market Attractiveness, by Product

7. Global Multiplex Assays Market Analysis, by Technology

  • 7.1. Introduction
  • 7.2. Key Findings
  • 7.3. Global Multiplex Assays Market Value Share Analysis, by Technology
  • 7.4. Global Multiplex Assays Market Value Forecast, by Technology, 2016?2026
    • 7.4.1. Multiplex RT-PCR
    • 7.4.2. Flow Cytometry
    • 7.4.3. Luminescence
    • 7.4.4. Fluorescence
    • 7.4.5. Others
  • 7.5. Global Multiplex Assays Market Attractiveness, by Technology

8. Global Multiplex Assays Market Analysis, by Type

  • 8.1. Introduction
  • 8.2. Key Findings
  • 8.3. Global Multiplex Assays Market Value Share Analysis, by Type
  • 8.4. Global Multiplex Assays Market Value Forecast, by Type, 2016?2026
    • 8.4.1. Protein
      • 8.4.1.1. Planar
      • 8.4.1.2. Bead-based
    • 8.4.2. Nucleic Acid
      • 8.4.2.1. Planar
      • 8.4.2.2. Bead-based
    • 8.4.3. Cell
  • 8.5. Global Multiplex Assays Market Attractiveness, by Type

9. Global Multiplex Assays Market Analysis, by Application

  • 9.1. Introduction
  • 9.2. Key Findings
  • 9.3. Global Multiplex Assays Market Value Share Analysis, by Application
  • 9.4. Global Multiplex Assays Market Value Forecast, by Application, 2016?2026
    • 9.4.1. Research & Development
      • 9.4.1.1. Drug Discovery & Research
      • 9.4.1.2. Biomarker Research & Application
    • 9.4.2. Diagnosis
      • 9.4.2.1. Infectious Diseases
      • 9.4.2.2. Autoimmune Diseases
      • 9.4.2.3. Cancer
      • 9.4.2.4. Cardiovascular Diseases
      • 9.4.2.5. Neuro-endocrine Diseases
      • 9.4.2.6. Others
    • 9.4.3. Others
  • 9.5. Global Multiplex Assays Market Attractiveness, by Application

10. Global Multiplex Assays Market Analysis, by End-user

  • 10.1. Introduction
  • 10.2. Key Findings
  • 10.3. Global Multiplex Assays Market Value Share Analysis, by End-user
  • 10.4. Global Multiplex Assays Market Value Forecast, by End-user, 2016?2026
    • 10.4.1. Academic & Research Centers
    • 10.4.2. Biotechnology & Biopharmaceutical Companies
    • 10.4.3. Diagnostic Centers
    • 10.4.4. Hospitals
    • 10.4.5. Others
  • 10.5. Global Multiplex Assays Market Attractiveness, by End-user

11. Global Multiplex Assays Market Analysis and Forecasts, by Region

  • 11.1. Introduction
  • 11.2. Regional Outlook
  • 11.3. Global Multiplex Assays Market Value Forecast, by Region, 2016-2026
    • 11.3.1. North America
    • 11.3.2. Europe
    • 11.3.3. Asia-Pacific
    • 11.3.4. Latin America
    • 11.3.5. Middle East & Africa
  • 11.4. Global Multiplex Assays Market Attractiveness Analysis, by Region

12. North America Multiplex Assays Market Analysis

  • 12.1. Key Findings
  • 12.2. North America Multiplex Assays Market Value Forecast by Country, 2016?2026
    • 12.2.1. U.S.
    • 12.2.2. Canada
  • 12.3. North America Multiplex Assays Market Value Forecast, by Product, 2016?2026
    • 12.3.1. Instruments
    • 12.3.2. Consumables
      • 12.3.2.1. Reagents & Kits
      • 12.3.2.2. Micropipettes & Microplates
      • 12.3.2.3. Others
    • 12.3.3. Software
  • 12.4. North America Multiplex Assays Market Value Forecast, by Technology, 2016?2026
    • 12.4.1. Multiplex RT-PCR
    • 12.4.2. Flow Cytometry
    • 12.4.3. Luminescence
    • 12.4.4. Fluorescence
    • 12.4.5. Others
  • 12.5. North America Multiplex Assays Market Value Forecast, by Type, 2016?2026
    • 12.5.1. Protein
      • 12.5.1.1. Planar
      • 12.5.1.2. Bead-based
    • 12.5.2. Nucleic Acid
      • 12.5.2.1. Planar
      • 12.5.2.2. Bead-based
    • 12.5.3. Cell
  • 12.6. North America Multiplex Assays Market Value Forecast, by Application, 2016?2026
    • 12.6.1. Research & Development
      • 12.6.1.1. Drug Discovery & Research
      • 12.6.1.2. Biomarker Research & Application
    • 12.6.2. Diagnosis
      • 12.6.2.1. Infectious Diseases
      • 12.6.2.2. Autoimmune Diseases
      • 12.6.2.3. Cancer
      • 12.6.2.4. Cardiovascular Diseases
      • 12.6.2.5. Neuro-endocrine Diseases
      • 12.6.2.6. Others
    • 12.6.3. Others
  • 12.7. North America Multiplex Assays Market Value Forecast, by End-user, 2016?2026
    • 12.7.1. Academic & Research Centers
    • 12.7.2. Biotechnology & Biopharmaceutical Companies
    • 12.7.3. Diagnostic Centers
    • 12.7.4. Hospitals
    • 12.7.5. Others
  • 12.8. North America Multiplex Assays Market Attractiveness
    • 12.8.1. By Country
    • 12.8.2. By Product
    • 12.8.3. By Technology
    • 12.8.4. By Type
    • 12.8.5. By Application
    • 12.8.6. By End-user

13. Europe Multiplex Assays Market Analysis

  • 13.1. Key Findings
  • 13.2. Europe Multiplex Assays Market Value Forecast by Country, 2016?2026
    • 13.2.1. Germany
    • 13.2.2. U.K.
    • 13.2.3. France
    • 13.2.4. Italy
    • 13.2.5. Spain
    • 13.2.6. Rest of Europe
  • 13.3. Europe Multiplex Assays Market Value Forecast, by Product, 2016?2026
    • 13.3.1. Instruments
    • 13.3.2. Consumables
      • 13.3.2.1. Reagents & Kits
      • 13.3.2.2. Micropipettes & Microplates
      • 13.3.2.3. Others
    • 13.3.3. Software
  • 13.4. Europe Multiplex Assays Market Value Forecast, by Technology, 2016?2026
    • 13.4.1. Multiplex RT-PCR
    • 13.4.2. Flow Cytometry
    • 13.4.3. Luminescence
    • 13.4.4. Fluorescence
    • 13.4.5. Others
  • 13.5. Europe Multiplex Assays Market Value Forecast, by Type, 2016?2026
    • 13.5.1. Protein
      • 13.5.1.1. Planar
      • 13.5.1.2. Bead-based
    • 13.5.2. Nucleic Acid
      • 13.5.2.1. Planar
      • 13.5.2.2. Bead-based
    • 13.5.3. Cell
  • 13.6. Europe Multiplex Assays Market Value Forecast, by Application, 2016?2026
    • 13.6.1. Research & Development
      • 13.6.1.1. Drug Discovery & Research
      • 13.6.1.2. Biomarker Research & Application
    • 13.6.2. Diagnosis
      • 13.6.2.1. Infectious Diseases
      • 13.6.2.2. Autoimmune Diseases
      • 13.6.2.3. Cancer
      • 13.6.2.4. Cardiovascular Diseases
      • 13.6.2.5. Neuro-endocrine Diseases
      • 13.6.2.6. Others
    • 13.6.3. Others
  • 13.7. Europe Multiplex Assays Market Value Forecast, by End-user, 2016?2026
    • 13.7.1. Academic & Research Centers
    • 13.7.2. Biotechnology & Biopharmaceutical Companies
    • 13.7.3. Diagnostic Centers
    • 13.7.4. Hospitals
    • 13.7.5. Others
  • 13.8. Europe Multiplex Assays Market Attractiveness
    • 13.8.1. By Country
    • 13.8.2. By Product
    • 13.8.3. By Technology
    • 13.8.4. By Type
    • 13.8.5. By Application
    • 13.8.6. By End-user

14. Asia Pacific Multiplex Assays Market Analysis

  • 14.1. Key Findings
  • 14.2. Asia Pacific Multiplex Assays Market Value Forecast by Country, 2016?2026
    • 14.2.1. China
    • 14.2.2. India
    • 14.2.3. Japan
    • 14.2.4. Australia
    • 14.2.5. Rest of Asia Pacific
  • 14.3. Asia Pacific Multiplex Assays Market Value Forecast, by Product, 2016?2026
    • 14.3.1. Instruments
    • 14.3.2. Consumables
      • 14.3.2.1. Reagents & Kits
      • 14.3.2.2. Micropipettes & Microplates
      • 14.3.2.3. Others
    • 14.3.3. Software
  • 14.4. Asia Pacific Multiplex Assays Market Value Forecast, by Technology, 2016?2026
    • 14.4.1. Multiplex RT-PCR
    • 14.4.2. Flow Cytometry
    • 14.4.3. Luminescence
    • 14.4.4. Fluorescence
    • 14.4.5. Others
  • 14.5. Asia Pacific Multiplex Assays Market Value Forecast, by Type, 2016?2026
    • 14.5.1. Protein
      • 14.5.1.1. Planar
      • 14.5.1.2. Bead-based
    • 14.5.2. Nucleic Acid
      • 14.5.2.1. Planar
      • 14.5.2.2. Bead-based
    • 14.5.3. Cell
  • 14.6. Asia Pacific Multiplex Assays Market Value Forecast, by Application, 2016?2026
    • 14.6.1. Research & Development
      • 14.6.1.1. Drug Discovery & Research
      • 14.6.1.2. Biomarker Research & Application
    • 14.6.2. Diagnosis
      • 14.6.2.1. Infectious Diseases
      • 14.6.2.2. Autoimmune Diseases
      • 14.6.2.3. Cancer
      • 14.6.2.4. Cardiovascular Diseases
      • 14.6.2.5. Neuro-endocrine Diseases
      • 14.6.2.6. Others
    • 14.6.3. Others
  • 14.7. Asia Pacific Multiplex Assays Market Value Forecast, by End-user, 2016?2026
    • 14.7.1. Academic & Research Centers
    • 14.7.2. Biotechnology & Biopharmaceutical Companies
    • 14.7.3. Diagnostic Centers
    • 14.7.4. Hospitals
    • 14.7.5. Others
  • 14.8. Asia Pacific Multiplex Assays Market Attractiveness
    • 14.8.1. By Country
    • 14.8.2. By Product
    • 14.8.3. By Technology
    • 14.8.4. By Type
    • 14.8.5. By Application
    • 14.8.6. By End-user

15. Latin America Multiplex Assays Market Analysis

  • 15.1. Key Findings
  • 15.2. Latin America Multiplex Assays Market Value Forecast by Country, 2016?2026
    • 15.2.1. Brazil
    • 15.2.2. Mexico
    • 15.2.3. Rest of Latin America
  • 15.3. Latin America Multiplex Assays Market Value Forecast, by Product, 2016?2026
    • 15.3.1. Instruments
    • 15.3.2. Consumables
      • 15.3.2.1. Reagents & Kits
      • 15.3.2.2. Micropipettes & Microplates
      • 15.3.2.3. Others
    • 15.3.3. Software
  • 15.4. Latin America Multiplex Assays Market Value Forecast, by Technology, 2016?2026
    • 15.4.1. Multiplex RT-PCR
    • 15.4.2. Flow Cytometry
    • 15.4.3. Luminescence
    • 15.4.4. Fluorescence
    • 15.4.5. Others
  • 15.5. Latin America Multiplex Assays Market Value Forecast, by Type, 2016?2026
    • 15.5.1. Protein
      • 15.5.1.1. Planar
      • 15.5.1.2. Bead-based
    • 15.5.2. Nucleic Acid
      • 15.5.2.1. Planar
      • 15.5.2.2. Bead-based
    • 15.5.3. Cell
  • 15.6. Latin America Multiplex Assays Market Value Forecast, by Application, 2016?2026
    • 15.6.1. Research & Development
      • 15.6.1.1. Drug Discovery & Research
      • 15.6.1.2. Biomarker Research & Application
    • 15.6.2. Diagnosis
      • 15.6.2.1. Infectious Diseases
      • 15.6.2.2. Autoimmune Diseases
      • 15.6.2.3. Cancer
      • 15.6.2.4. Cardiovascular Diseases
      • 15.6.2.5. Neuro-endocrine Diseases
      • 15.6.2.6. Others
    • 15.6.3. Others
  • 15.7. Latin America Multiplex Assays Market Value Forecast, by End-user, 2016?2026
    • 15.7.1. Academic & Research Centers
    • 15.7.2. Biotechnology & Biopharmaceutical Companies
    • 15.7.3. Diagnostic Centers
    • 15.7.4. Hospitals
    • 15.7.5. Others
  • 15.8. Latin America Multiplex Assays Market Attractiveness
    • 15.8.1. By Country
    • 15.8.2. By Product
    • 15.8.3. By Technology
    • 15.8.4. By Type
    • 15.8.5. By Application
    • 15.8.6. By End-user

16. Middle East & Africa Multiplex Assays Market Analysis

  • 16.1. Key Findings
  • 16.2. Middle East & Africa Multiplex Assays Market Value Forecast by Country, 2016?2026
    • 16.2.1. GCC Countries
    • 16.2.2. Israel
    • 16.2.3. South Africa
    • 16.2.4. Rest of Middle East & Africa
  • 16.3. Middle East & Africa Multiplex Assays Market Value Forecast, by Product, 2016?2026
    • 16.3.1. Instruments
    • 16.3.2. Consumables
      • 16.3.2.1. Reagents & Kits
      • 16.3.2.2. Micropipettes & Microplates
      • 16.3.2.3. Others
    • 16.3.3. Software
  • 16.4. Middle East & Africa Multiplex Assays Market Value Forecast, by Technology, 2016?2026
    • 16.4.1. Multiplex RT-PCR
    • 16.4.2. Flow Cytometry
    • 16.4.3. Luminescence
    • 16.4.4. Fluorescence
    • 16.4.5. Others
  • 16.5. Middle East & Africa Multiplex Assays Market Value Forecast, by Type, 2016?2026
    • 16.5.1. Protein
      • 16.5.1.1. Planar
      • 16.5.1.2. Bead-based
    • 16.5.2. Nucleic Acid
      • 16.5.2.1. Planar
      • 16.5.2.2. Bead-based
    • 16.5.3. Cell
  • 16.6. Middle East & Africa Multiplex Assays Market Value Forecast, by Application, 2016?2026
    • 16.6.1. Research & Development
      • 16.6.1.1. Drug Discovery & Research
      • 16.6.1.2. Biomarker Research & Application
    • 16.6.2. Diagnosis
      • 16.6.2.1. Infectious Diseases
      • 16.6.2.2. Autoimmune Diseases
      • 16.6.2.3. Cancer
      • 16.6.2.4. Cardiovascular Diseases
      • 16.6.2.5. Neuro-endocrine Diseases
      • 16.6.2.6. Others
    • 16.6.3. Others
  • 16.7. Middle East & Africa Multiplex Assays Market Value Forecast, by End-user, 2016?2026
    • 16.7.1. Academic & Research Centers
    • 16.7.2. Biotechnology & Biopharmaceutical Companies
    • 16.7.3. Diagnostic Centers
    • 16.7.4. Hospitals
    • 16.7.5. Others
  • 16.8. Middle East & Africa Multiplex Assays Market Attractiveness
    • 16.8.1. By Country
    • 16.8.2. By Product
    • 16.8.3. By Technology
    • 16.8.4. By Type
    • 16.8.5. By Application
    • 16.8.6. By End-user

17. Competitive Landscape

  • 17.1. Competition Matrix
  • 17.2. Company Profiles
    • 17.2.1. Luminex Corporation
      • 17.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.1.2. Financial Overview
      • 17.2.1.3. Product Portfolio
      • 17.2.1.4. SWOT Analysis
      • 17.2.1.5. Strategic Overview
    • 17.2.2. Thermo Fisher Scientific, Inc.
      • 17.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.2.2. Financial Overview
      • 17.2.2.3. Product Portfolio
      • 17.2.2.4. SWOT Analysis
      • 17.2.2.5. Strategic Overview
    • 17.2.3. Seegene, Inc.
      • 17.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.3.2. Financial Overview
      • 17.2.3.3. Product Portfolio
      • 17.2.3.4. SWOT Analysis
      • 17.2.3.5. Strategic Overview
    • 17.2.4. Meso Scale Diagnostics, LLC.
      • 17.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.4.2. Product Portfolio
      • 17.2.4.3. SWOT Analysis
      • 17.2.4.4. Strategic Overview
    • 17.2.5. Abcam plc
      • 17.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.5.2. Financial Overview
      • 17.2.5.3. Product Portfolio
      • 17.2.5.4. SWOT Analysis
      • 17.2.5.5. Strategic Overview
    • 17.2.6. Bio-Rad Laboratories, Inc.
      • 17.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.6.2. Financial Overview
      • 17.2.6.3. Product Portfolio
      • 17.2.6.4. SWOT Analysis
      • 17.2.6.5. Strategic Overview
    • 17.2.7. QIAGEN N.V.
      • 17.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.7.2. Financial Overview
      • 17.2.7.3. Product Portfolio
      • 17.2.7.4. SWOT Analysis
      • 17.2.7.5. Strategic Overview
    • 17.2.8. Merck KGaA
      • 17.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.8.2. Financial Overview
      • 17.2.8.3. Product Portfolio
      • 17.2.8.4. SWOT Analysis
      • 17.2.8.5. Strategic Overview
    • 17.2.9. Quansys Biosciences
      • 17.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.9.2. Product Portfolio
      • 17.2.9.3. SWOT Analysis
    • 17.2.10. Illumina, Inc.
      • 17.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.2.10.2. Financial Overview
      • 17.2.10.3. Product Portfolio
      • 17.2.10.4. SWOT Analysis
      • 17.2.10.5. Strategic Overview